Join us now. Sylvia Jablonsky, Defiance ETF CEO uh and chief me chief investment officer. I I'm I'm feeling I'm feeling you have not been that negative.No. Throughout all this, I I can remember I it's sad because I look at some people and I remember how wrong they were. Yeah.And we have a lot of people on that when I look at now that's all I can think about and I'm not sure why they're here. Glad I'm glad I'm not one of them for You're not one of them. You are not one of them.Why didn't you Um it wasn't a h ...

Welcome back to Squawk. Microsoft Open AAI and Anthropic. They're all teaming up with the American Federation of Teachers to offer free AI training um to AFT members.The $23 million initiative is going to focus on AI tools for K through2 educators. Joining us right now is Randy Weine, president of the American Federation of Teachers. Good morning to you. AI, of course, uh good morning.All sorts of controversy about uh how teachers should use it, how students should use it. tell us about uh at least how this ...

surprised at all about this reaction with the US markets. We're seeing futures pull back a bit. We'd heard a lot about the the taco trade, quote unquote Trump always chickens out.Do you believe that investors now believe that these tariffs will take place on August the 1st. Uh, no. I I I think that clearly I think markets would be quite a bit lower if investors expected uh a reversion to, you know, near liberation day tariffs for a lot of countries in a couple of weeks.I think that pushing the the deadline ...

Looking at earning season, Tekkenom Services, according to Lseg, uh they make up pretty much all the earnings growth this earning season. Without them, earnings growth would actually be negative. Do you think that Technom Services can live up to it.What are the potential pitfalls here. I mean, look, I think we're actually going to see an accelerated growth when it comes to earning season. The big thing here, it's you're seeing on the consumer side for what's like a Netflix subscription growth, especially in ...

I was just referring to the VIX a short time ago with our guest. Um during this quarter, the VIX spiked up to above 50. Now it's kind of settled down to 171 18.Are there any banks that are going to benefit specifically from some of that volatility earlier in the quarter like we saw last quarter where banks said they saw higher trading volume and they kind of benefited from the idea that investors weren't quite sure what to do. Sure. And thanks again for having me.We've noticed um and looking forward to this ...

Geopolitical Strategy & Sanctions - The US aims to strategically influence the Russia-Ukraine conflict through potential new measures [4] - Proposed sanctions could impose levies of up to 500% on countries purchasing Russian oil, uranium, and gas [5] - The effectiveness of sanctions hinges on the President's discretion and ability to wield them appropriately [7] - Sanctions primarily target countries like China and India that purchase Russian oil via the shadow fleet [7] Conflict Resolution & Negotiation - Ending the conflict in Ukraine is a top priority, aiming for a ceasefire and lasting peace [6] - Russia has gained approximately 025% of Ukrainian territory in the past year, highlighting the catastrophic nature of the conflict [8] - Ukraine has reportedly offered to cede 20% of its land in a potential peace deal, but Russia is stalling negotiations [9] - The US seeks to leverage negotiations to bring Russia to the table and achieve a ceasefire [11] US Foreign Policy & Diplomacy - The US is providing Patriot systems to Ukraine, funded by European NATO members [3] - The US emphasizes the importance of both Ukraine and Russia's willingness to negotiate in good faith to end the conflict [12]

Trade and Tariffs - Potential new tariffs on the EU and Mexico starting August 1st are being considered, primarily as a negotiating tactic to achieve broader policy goals beyond just trade [1][5] - The market impact of these potential tariffs on European markets has been limited, possibly because investors view them as temporary threats [3] - The shift from free trade to "friend trade" reflects a broader strategy of prioritizing close relationships in global trade [2] Earnings and Market Outlook - Earnings season is approaching, with a positive outlook expected later in the year, potentially boosted by a 10%+ move in the dollar [7] - AI is expected to drive cost reduction and margin improvement for smaller companies, potentially starting next year [8][11] - Tech and communication services are driving most of the earnings growth; without them, overall earnings growth would be negative [9] Investment Opportunities - Smaller value companies outside the Mag 7, trading at 13-14 times earnings, may benefit from AI adoption [11] - In Europe, investment opportunities exist in defense and infrastructure sectors due to increased spending [13][14] - In Asia, tech-oriented markets are preferred over goods-dependent markets due to potential tariff impacts [16][17] Market Valuation - The Mag 7 stocks are trading at approximately 31 times forward earnings, while the rest of the market is just under 21 times [9] - The earnings growth spread between the Mag 7 and the rest of the market is compressing, suggesting potential outperformance of smaller caps [10][11]

Potential Impact of Tariffs on European Pharmaceutical Companies - Determining which European pharmaceutical company would be most impacted by potential tariffs is difficult due to complex and opaque supply chains [1] - Novo Nordisk has been highlighted due to the manufacturing of active pharmaceutical ingredient for Wegovy (WGO) in Denmark [2] - The pharmaceutical sector is currently out of favor due to tariffs and other reasons [3] Lobbying and Manufacturing Investments in the US - European companies are making significant announcements about manufacturing investments in the United States [4] - Companies are working with the administration on the most favored nation drug pricing policy, potentially connected to tariffs [5] - Almost every major large-cap European company has announced extensive investments in the United States [10] Tariff Specifics and Potential Carveouts - The pharmaceutical sector is currently carved out from country-specific tariffs, contributing to the outperformance of the European healthcare index [7] - The market is awaiting results of a Section 232 investigation from the Commerce Department regarding sector-specific tariffs, with expectations of a 25% tariff before the mention of 200% [8] - The industry argues that tariffs will negatively impact patients and could result in drug shortages [9] Company Actions and Considerations - AstraZeneca is considering changing its registration to the US [10] - All European-based companies are emphasizing their commitment to the US and manufacturing in the US [10]

Five things to know ahead of today's opening bell. Warner Brothers Superman reboot topping the weekend box office brought in $122 million in the United States and Canada in its debut weekend. Its global hall estimated two at $217 million.The movie cost $225 million to produce. Of course, there are marketing costs on top of that. Shoppers spending heavily online from last Tuesday to Friday, what some are calling Black Friday and summer.That was led by Amazon's Prime Day, Adobe Analytics, saying that online s ...

Shares of Craft Hind in focus this morning. That follows a Wall Street Journal report late last week that the company is planning to break itself up by spinning off a chunk of its grocery business into a new entity that could be valued at up to $20 billion. According to the report, the remaining company would house sauce brands like Hines Ketchup and Gray Poop Mustard.Craft Hind was formed in 2015 after Bergkshire Hathway and Brazilian private equity firm 3G Capital combined Craft Foods with HJ Hines. Those ...